Analyst Reco. Definitive Healthcare Corp.

Equities

DH

US24477E1038

Market Closed - Nasdaq Other stock markets 21:00:00 02/05/2024 BST			5-day change	1st Jan Change
6.99 ^USD	+0.29%		+3.86%	-29.68%

04-16	Definitive Healthcare Introduces Carevoyance Sales Enablement Solution for Medtech Industry	CI
03-22	Definitive Healthcare Collaborating With VML Health on Key Opinion Leader Management Tool for Clients	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Adjusts Definitive Healthcare Price Target to $10 From $9, Maintains Hold Rating	03-01	MT
Barclays Adjusts Price Target on Definitive Healthcare to $11 From $10, Maintains Equalweight Rating	03-01	MT
Stifel Adjusts Definitive Healthcare's Price Target to $11 From $12, Keeps Buy Rating	01-17	MT
Needham Downgrades Definitive Healthcare to Hold From Buy	01-17	MT
Canaccord Genuity Downgrades Definitive Healthcare to Hold From Buy, Price Target is $10	01-05	MT
Barclays Raises Definitive Healthcare Price Target to $10 From $7, Maintains Equal Weight Rating	12-27	MT
Deutsche Bank Cuts Definitive Healthcare Price Target to $9 From $14, Maintains Hold rating	11-06	MT
Morgan Stanley Lowers Price Target on Definitive Healthcare to $9.50 From $15.50, Maintains Overweight Rating	11-03	MT
Goldman Sachs Adjusts Price Target on Definitive Healthcare to $10.50 From $17, Keeps Neutral Rating	15/08/23	MT
Credit Suisse Adjusts Price Target on Definitive Healthcare to $11 From $12, Keeps Neutral Rating	15/08/23	MT
Canaccord Genuity Adjusts Price Target on Definitive Healthcare to $12 From $13, Maintains Buy Rating	15/08/23	MT
Morgan Stanley Adjusts Price Target on Definitive Healthcare to $15.50 From $17, Maintains Overweight Rating	15/08/23	MT
BofA Adjusts Price Target on Definitive Healthcare to $10.50 From $12, Keeps Neutral Rating	15/08/23	MT
Baird Downgrades Definitive Healthcare to Neutral From Outperform, Price Target is $13	24/07/23	MT
Barclays Adjusts Price Target on Definitive Healthcare to $10 From $11, Maintains Equalweight Rating	08/05/23	MT
Credit Suisse Lowers Definitive Healthcare's Price Target to $12 From $15, Keeps Neutral Rating	05/05/23	MT
William Blair Reinstates Definitive Healthcare at Outperform Rating	19/04/23	MT
Morgan Stanley Adjusts Price Target on Definitive Healthcare to $17 From $18, Maintains Overweight Rating	28/02/23	MT
Credit Suisse Lowers Definitive Healthcare's PT to $15 From $19, Says Outlook Continues to be Weighed by Long Sales Cycles; Keeps Neutral Rating	24/02/23	MT
Morgan Stanley Adjusts Price Target on Definitive Healthcare to $18 From $21, Maintains Overweight Rating	06/01/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Definitive Healthcare Corp.

Equities

DH

US24477E1038

Analyst Reco.

Filters